Fidelity Small-Mid Multifactor ETF (FSMD)

The Fidelity Small-Mid Multifactor ETF (NASDAQ: FSMD) does not track a single size or style — it blends small and mid-cap stocks and tilts toward those that exhibit multiple desirable traits: cheap valuations, strong profitability, robust earnings momentum, and low volatility. It is a systematic attempt to let investors capture the long-term returns of smaller companies while filtering for quality and avoiding the worst value traps.

The multifactor thesis: why one factor is not enough

Academic finance has identified several persistent stock-market anomalies. Value — buying cheap stocks — works over long periods. Quality — holding companies with strong balance sheets and real earnings — works. Momentum — riding stocks that have recently outperformed — works. Low volatility — owning stocks that bounce around less — sometimes works. But each of these factors goes in and out of favour. Value leads for five years, then crashes. Momentum works during bull markets, fails during crashes.

The insight behind multifactor funds like FSMD is that diversifying across multiple factors should smooth returns and reduce reliance on any single anomaly continuing to work. If you own a basket of stocks that are cheap and profitable and have positive momentum and are not too volatile, you gain resilience. When value crashes, momentum or quality might be holding up. When momentum fails, value might be rebounding. The theory is that you cannot time which factor will work, so own all of them at once.

Fidelity built FSMD to test this thesis in the small- and mid-cap space, where data is patchier, stocks are less liquid, and market inefficiencies should be larger than in the mega-cap realm.

How the screen actually works

FSMD starts with the universe of U.S. stocks between roughly $300 million and $10 billion in market capitalization — a slice that captures both small-cap growth companies and mid-cap established businesses. Fidelity then scores each stock on four key dimensions.

Valuation: Price-to-book, price-to-earnings, enterprise value relative to earnings and cash flow. Cheaper stocks get higher scores. But the filter avoids true bankruptcy-risk junk; it is not pursuing the single-digit price-to-earnings names that are cheap because they are dying.

Quality: Return on equity, earnings stability, balance-sheet strength, free cash flow generation. A company with high ROE, consistent earnings, and low debt gets a high quality score. A profitable company that is reinvesting heavily for growth also scores well.

Momentum: The stock’s recent price performance over the past 6 to 12 months. Stocks that have outperformed recently get a boost, on the theory that early winners tend to continue winning for at least a short further period.

Volatility: Historical price swings. Less-volatile stocks get higher scores, reflecting that many investors prefer steadier holdings and that low-volatility stocks have delivered somewhat better risk-adjusted returns than theory predicts.

Fidelity assigns a composite score to each stock based on these four measures and tilts the FSMD portfolio toward high-scoring names. The fund holds 200 to 300 positions — enough for diversification, not so many that every stock is included. The largest holding rarely exceeds 2 per cent; the top ten holdings are perhaps 15–20 per cent of the fund.

The shape of the resulting portfolio

Because FSMD tilts toward value, quality, and low volatility while maintaining small- and mid-cap exposure, its holdings tend to cluster in certain sectors. Industrials fare well (many are profitable, slow-growing, cheap, and boring — exactly the quality+value profile FSMD rewards). Financials show up regularly (banks are cyclical, but when healthy and not leveraged to the hilt, they can be good quality-factor vehicles). Healthcare services (not biotech) can appear. Utilities show up because they are stable, low-volatility, dividend-paying. Energy and materials cyclicals occasionally appear when cheap with positive momentum.

What FSMD avoids: high-flying unprofitable tech startups (they fail the quality test), speculative biotech (too volatile), and distressed financial firms (too risky). The fund is hunting for steady, improving, reasonably priced mid-size companies, not the next unicorn.

Geographically, FSMD is 100 per cent domestic U.S., reflecting both Fidelity’s expertise and the fact that multifactor screening works best within a single, deeply analysed market.

When multifactor strategies fail

Multifactor funds work brilliantly until they do not. The risk is that correlations break and all of your tilts go bad at once. Imagine a scenario in which growth suddenly dominates (as it did from 2017 to 2020): unprofitable, expensive, volatile tech companies shoot up while value, quality, and low-volatility lag together. In such an environment, FSMD would badly underperform a simple growth-tilted small-cap index.

There is also the problem of factor crowding. If multifactor investing becomes popular and trillions flow into value, quality, and momentum, factor premiums compress. What worked historically because it was ignored by institutional investors no longer works because everyone owns it. The fees (FSMD runs 0.35–0.50 per cent) can then exceed the outperformance delivered, making the fund a drag rather than a boost.

A third risk is that the scoring methodology itself breaks down. Academic factors are measured on decades of data; the variables that worked from 1950 to 2020 might not work from 2025 to 2035. Fidelity monitors and updates its methodology, but you cannot guarantee that the refresh will help rather than hurt.

Fidelity’s execution and the cost of active screening

Unlike a true index fund, FSMD requires active managers to score stocks and rebalance the portfolio. That costs money: the fund’s expense ratio is higher than a passive small-cap-index fund (0.35–0.50 per cent versus 0.04–0.08 per cent) but lower than a full-discretionary active small-cap fund (which might run 0.75–1.25 per cent).

Fidelity’s pitch is that the active screening layer justifies its fee by capturing outperformance that the four factors should deliver. But this is an empirical question: does FSMD beat a simple equal-weight blend of the four factors over rolling 3- and 5-year periods? Fidelity has a track record suggesting yes, but investors should verify independently rather than assume Fidelity’s branding alone delivers value.

The liquidity and size question

FSMD holds small and mid-cap stocks, which are less liquid than large caps. A sudden surge in redemptions could force FSMD to sell positions at unfavourable prices. The fund mitigates this by holding a broad range of positions (200+ stocks) rather than concentrating in the most liquid handful, but you cannot eliminate liquidity risk.

Additionally, the small-to-mid-cap space can be crowded. During periods of rotation toward mega-cap tech, small-cap funds are all selling simultaneously; during rotations back to quality or value, they are all buying. This herding can move the market against FSMD holders.

How a reader would research this fund

Start with Fidelity’s detailed fact sheet, which explains the multifactor methodology in depth and breaks down what the fund actually holds (sector exposure, top ten holdings, geographic breakdown, valuations relative to its benchmark).

Compare FSMD’s rolling 3- and 5-year returns to a simple small-cap-value index like the Russell 2000 Value or the iShares Russell 2000 Value (IWN). Has FSMD beaten that passive alternative after fees? If not, the multifactor overlay is not adding value and you are better off buying the simple index.

Look at Fidelity’s annual reports for turnover metrics. High turnover (above 50 per cent per year) means the fund is trading a lot, which can create tax drag and hidden costs. Lower turnover (below 30 per cent) is a sign of a stable, disciplined approach.

Finally, examine FSMD’s performance during the 2020 pandemic crash and the 2022 rate-driven crash. Did the low-volatility and quality tilts actually reduce drawdowns? Or did small-cap weakness dominate and erase the benefit of the factor overlays? That history reveals whether the multifactor approach genuinely delivers the diversification it promises.

Ask yourself: do you believe that value, quality, momentum, and low volatility will all outperform together over the next five years? If yes, FSMD is a coherent holding. If you think one or more of these factors will badly lag, you are taking a bet that might not pay off.